Meghan Price
Family · Anderson, INNPI 1225509615
Payments from drug & device makers
Across 294 payments — averaging $24.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Boehringer Ingelheim$998
- Novartis$783
- Abbott$520
- Amgen$502
- Esperion Therapeutics, Inc.$361
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,88297%
- Education$2203%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 45 | $1,702 |
| Boehringer Ingelheim | 38 | $998 |
| Novartis | 47 | $783 |
| Abbott | 7 | $520 |
| Amgen | 39 | $502 |
| Esperion Therapeutics, Inc. | 9 | $361 |
| Scpharmaceuticals Inc. | 11 | $330 |
| Bayer | 22 | $276 |
| Merck | 10 | $186 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $163 |
| Cvrx, Inc. | 3 | $148 |
| Novo Nordisk | 6 | $138 |
| GSK | 7 | $135 |
| Johnson & Johnson | 8 | $124 |
| E.r. Squibb & Sons, L.L.C. | 7 | $114 |
| Pfizer | 6 | $108 |
| Lexicon Pharmaceuticals, Inc. | 6 | $107 |
| Regeneron Healthcare Solutions, Inc. | 4 | $88 |
| Boston Scientific | 1 | $76 |
| Grifols USA, LLC | 3 | $65 |
| Philips North America LLC | 2 | $35 |
| Viatris Specialty LLC | 1 | $31 |
| Tactile Systems Technology Inc | 2 | $30 |
| Abiomed | 1 | $27 |
| Kestra Medical Technology Services, Inc. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$456
- FARXIGA$452
- CARDIOMEMS$284
- MitraClip$160
- FUROSCIX$125
- LOKELMA$124
- Barostim Neo System$122
- NEXLIZET$121
- NEXLETOL$121
How this compares
$7,102 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 415 | $452,532 |
| Repatha SureclickEvolocumab | 260 | $287,833 |
| JardianceEmpagliflozin | 237 | $235,610 |
| FarxigaDapagliflozin Propanediol | 153 | $128,047 |
| EliquisApixaban | 118 | $118,434 |
| Praluent PenAlirocumab | 38 | $31,384 |
| OzempicSemaglutide | 21 | $28,980 |
| NexlizetBempedoic Acid/Ezetimibe | 46 | $25,364 |
| BrilintaTicagrelor | 11 | $12,862 |
| NexletolBempedoic Acid | 20 | $10,887 |
| VascepaIcosapent Ethyl | 23 | $9,550 |
| Icosapent Ethyl | 24 | $6,861 |
| XareltoRivaroxaban | 12 | $6,626 |
| Torsemide | 287 | $4,416 |
| Metoprolol Succinate | 244 | $3,634 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $783 | $452,532415 claims |
| Boehringer IngelheimJardiance | $998 | $235,610237 claims |
| AstraZenecaFarxiga, Brilinta | $1,702 | $140,909164 claims |
| PfizerEliquis | $108 | $118,434118 claims |
| Esperion Therapeutics, Inc.Nexlizet, Nexletol | $361 | $36,25166 claims |
| Novo NordiskOzempic | $138 | $28,98021 claims |
| Johnson & JohnsonXarelto | $124 | $6,62612 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,392 family providers in Indiana.
Other family in Anderson
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.